- ICH GCP
- Registr klinických studií v USA
- Klinická studie NCT02374463
Improving Balance and Mobility (MMBI)
Improving Balance and Mobility in Older Veterans
Přehled studie
Postavení
Intervence / Léčba
Detailní popis
Background: Falls are currently the leading cause of injurious death and non-fatal injuries for adults over the age of 65. Older Veterans may be at greater risk for falls due to their high burden of medical co-morbidity. The VA has made research into fall prevention a high priority. Falls are complex with numerous deficits including impaired balance, decreased postural control, muscle weakness, and an inability to successfully negotiate environmental hazards. Tai Chi is currently considered to be one of the most effective fall prevention exercise interventions, with an endorsement from the Centers for Disease Control and Prevention (CDC) which widely influences health care policy. However, there are few studies comparing Tai Chi with another active intervention. Tai Chi may generally improve balance, decrease fall risk, and provides a general lower body strengthening. However, Tai Chi may not sufficiently improve gait and dynamic mobility and does little to target obstacle negotiation, one of the largest contributors to a fall. The majority of falls occur during walking, with slips and trips being the most common causes and targeted interventions focused on improving stepping and walking ability may be even more effective at improving balance and reducing falls.
The Investigators plan to enroll 56 older (age > 65 years) community dwelling Veterans with a history of a fall in the last year who are at high risk for a recurrent fall. After baseline testing participants will be randomized to either MMBI or a Tai Chi intervention modeled after the Tai Chi Moving for Better Balance Program. All participants will participate in a group exercise class in their assigned intervention for 1 hour, 3 times per week for 24 weeks. After the completion of 24 weeks of exercise group changes will be compared for 1) balance (4-square step test); 2) mobility and fall risk (functional gait assessment); 3) rate of falls; 4) lower extremity isometric strength testing (biodex); and 5) body composition. The investigators also plan for follow all participants for 6 months after completion of the intervention to examine differences in fall rates after the cessation of the program between the groups.
Impact: This research directly benefits Veterans as it may lead to new and effective interventions that could reduce fall risk, injury-related hospitalization and death in older Veterans. MMBI is also readily exportable to the community and with minimal resources could be widely implemented at other VAs as part of standard of care, similar to Managing Overweight and/or Obesity for Veterans Everywhere! (MOVE!). Results from this SPIRE grant will be used to power a larger randomized clinical trial that will examine the effectiveness of the two interventions to reduce rate of falls and risk of falling in older Veterans at high risk for falls.
Typ studie
Zápis (Aktuální)
Fáze
- Nelze použít
Kontakty a umístění
Studijní místa
-
-
Maryland
-
Baltimore, Maryland, Spojené státy, 21201
- Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD
-
-
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
Přijímá zdravé dobrovolníky
Pohlaví způsobilá ke studiu
Popis
Inclusion Criteria:
- 65 years of age and older
- Mobility and balance limitations as demonstrated by a self-reported fall within the past year or requiring greater than 8 seconds to complete the 4-square step test
Exclusion Criteria:
- Cardiovascular Risks: Poorly controlled hypertension (>160/100); Class III or IV congestive heart failure (CHF); or patient report of: symptomatic angina at rest or during exercise, syncope without known resolution of cause, or a significant coronary event (such as a MI) in the past six months
- Chronic obstructive pulmonary disease (COPD) requiring home oxygen
- Contraindications to resistance training, including a self-reported history of intracranial or retinal bleeding in the last year or Diabetes with active proliferative retinopathy
- Patient report of significant spinal stenosis that would limit participation in the exercise intervention -Dementia (on medical record review or mini-mental status exam score <24).
- Non-ambulatory mobility status or a transtibial or transfemoral amputation
- Other severe medical illness or condition that would preclude safe participation in the study as determined by the study team
Studijní plán
Jak je studie koncipována?
Detaily designu
- Primární účel: Prevence
- Přidělení: Randomizované
- Intervenční model: Paralelní přiřazení
- Maskování: Singl
Zbraně a zásahy
Skupina účastníků / Arm |
Intervence / Léčba |
|---|---|
|
Experimentální: Multimodality Balance Intervention (MMBI)
|
Multimodality Balance Intervention (MMBI): Our MMBI will be held 3-times a week for an hour and will consist of a group dynamic balance class (30 minutes), a supervised obstacle course (10 minutes), and lower extremity and core strengthening (20 minutes).
The group exercise classes will focus on dynamic weight shifts with an emphasis on the lateral and diagonal directions.
Over the 6 months of class, the exercises will gradually increase in difficulty to challenge balance.
A skilled instructor will lead each class and 1-2 assistants will be present to assist with fall risk prevention.
The supervised obstacle course will focus on obstacle negotiation, gait over challenging surfaces, and moving in lateral, diagonal, and backward directions.
Finally, strength training of the lower extremities and core will focus on strengthening major muscles of the lower extremity and core utilizing commonly available gym equipment, ankle weights and body weight.
|
|
Aktivní komparátor: Tai Chi
Tai Chi Intervention
|
Tai Chi Intervention: The supervised Tai Chi class will be held 3-times a week for one hour.
All Tai Chi classes will be taught in a group setting by an experienced instructor.
The emphasis during the class will be on standing movements, body alignment, weight shift and changes of direction.
Movements will be adapted as the class progresses to increase the difficulty of weight shift and change in direction over time so that participants balance is continually challenged throughout the 6 months.
Chairs or hand rails will be available for the participants to use as needed for balance recovery.
|
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Balance and Lateral Mobility Assessed by the Four Square Step Test
Časové okno: The FSST was assessed at 6 month (post) and at baseline (pre)
|
the Four Square Step Test assesses dynamic balance and coordination through stepping forwards, sideways, and backwards in a timed fashion.
The four square step test is timed in seconds.
Higher scores are associated with worse outcome.
Individuals with higher scores are at increased risk of falling with some using a score of 15 seconds or higher as being at high risk for falls.
The minimum value one would see in young healthy populations for this test is 5 seconds.
The maximum value is 60 seconds.
If they are deemed unable to complete the value is not reported
|
The FSST was assessed at 6 month (post) and at baseline (pre)
|
Sekundární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Functional Gait Analysis
Časové okno: FGA ws measured at 6 months (post) and at baseline (pre)
|
The Functional Gait Assessment (FGA) is designed to assess postural stability during gait.
The measure is calculated by summing the scores for 10 gait related tasks.
Each task is scored from 3 to 0, where 3 is the best possible performance (normal) and 0 indicates severe impairment related to the task.
The best possible score is 30 and the worst possible score is 0. Higher values are associated with better outcome.
A value of 22/30 and below is associated with high risk of falling in the community.
|
FGA ws measured at 6 months (post) and at baseline (pre)
|
|
Change in Strength R Knee Biodex
Časové okno: Strength at the R knee was assessed at 6 months (post) and at baseline (pre)
|
Change in isometric strength R knee assessed using the biodex measured before and after intervention.
Change was calculated as value at 6 months (post)-value at baseline (pre).Higher values are a better outcome
|
Strength at the R knee was assessed at 6 months (post) and at baseline (pre)
|
|
Number of Subjects Who Reported Falls
Časové okno: 6 months
|
This is the number of subjects who self-reported at least one fall, and does not include trips or near falls.
This measure does not include the total number of falls as there were several participants who reported more than one fall.
|
6 months
|
|
Change in Strength R Hip Using Biodex
Časové okno: Strength in the R hip was assessed at 6 months (post) and at baseline (pre)
|
Assessment of change in strength using biodex.
Higher values are associated with better outcome
|
Strength in the R hip was assessed at 6 months (post) and at baseline (pre)
|
Další výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Percent Body Fat
Časové okno: 6 months
|
change in total body fat measured using Dual-energy X-ray absorptiometry (DXA).
Value was calculated as value at 6 months (post) - value at baseline (pre)
|
6 months
|
Spolupracovníci a vyšetřovatelé
Vyšetřovatelé
- Vrchní vyšetřovatel: Leslie Ira Katzel, MD PhD, Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD
Publikace a užitečné odkazy
Obecné publikace
- Dite W, Temple VA. A clinical test of stepping and change of direction to identify multiple falling older adults. Arch Phys Med Rehabil. 2002 Nov;83(11):1566-71. doi: 10.1053/apmr.2002.35469.
- Wrisley DM, Marchetti GF, Kuharsky DK, Whitney SL. Reliability, internal consistency, and validity of data obtained with the functional gait assessment. Phys Ther. 2004 Oct;84(10):906-18.
Užitečné odkazy
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia (Aktuální)
Primární dokončení (Aktuální)
Dokončení studie (Aktuální)
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Odhad)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Klíčová slova
Další relevantní podmínky MeSH
Další identifikační čísla studie
- E1574-P
- 1I21RX001574-01A1 (Grant/smlouva NIH USA)
Plán pro data jednotlivých účastníků (IPD)
Plánujete sdílet data jednotlivých účastníků (IPD)?
Informace o lécích a zařízeních, studijní dokumenty
Studuje lékový produkt regulovaný americkým FDA
Studuje produkt zařízení regulovaný americkým úřadem FDA
produkt vyrobený a vyvážený z USA
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .
Klinické studie na MMBI
-
University of Colorado, BoulderDokončenoDeprese | Deprese, poporodní období | Související s těhotenstvím | Předporodní depreseSpojené státy
-
Oregon Research Behavioral Intervention Strategies...National Institute of Mental Health (NIMH)DokončenoPerinatální depreseSpojené státy
-
University of Colorado, BoulderUniversity of Toronto; Children's Hospital Medical Center, Cincinnati; University... a další spolupracovníciDokončeno
-
Sierra Oncology LLC - a GSK companyDokončenoPrimární myelofibróza (PMF) | Post-polycythemia Vera (Post-PV) Myelofibróza | Postesenciální trombocytémie (Post-ET) myelofibrózaSpojené státy, Kanada
-
GlaxoSmithKlineAktivní, ne náborNovotvary | Primární myelofibróza | Primární myelofibróza (PMF) | Post-polycythemia Vera Myelofibrosis (Post-PV MF) | Post-esenciální trombocytémie myelofibróza (Post-ET MF)Spojené státy, Tchaj-wan, Itálie, Španělsko, Belgie, Kanada, Austrálie, Izrael, Singapur, Dánsko, Maďarsko, Rumunsko, Spojené království, Bulharsko, Rakousko, Francie, Německo, Polsko, Holandsko, Jižní Korea
-
Sierra Oncology, Inc.UkončenoRelapsed Metastatic KRAS-Mutated Non-Small Cell Lung CancerSpojené státy
-
Sierra Oncology, Inc.UkončenoRecidivující/refrakterní metastatický duktální adenokarcinom slinivky břišníSpojené státy
-
Sierra Oncology, Inc.UkončenoEGFR mutovaný EGFR TKI Naivní metastatický NSCLCSpojené státy
-
Sierra Oncology LLC - a GSK companyDokončenoPrimární myelofibróza | Post-polycythemia Vera Myelofibróza | Postesenciální trombocytémie MyelofibrózaKorejská republika, Kanada, Maďarsko, Izrael, Španělsko, Spojené státy, Austrálie, Tchaj-wan, Singapur, Německo, Itálie, Francie, Belgie, Nový Zéland, Rakousko, Spojené království, Dánsko, Bulharsko, Polsko, Česko, Rumunsko, Švédsko